Fredun Pharma Sets July 16, 2026 Record Date for 2:1 Bonus Issue

Fredun Pharmaceuticals Ltd has announced July 16, 2026, as the record date for its upcoming bonus equity share issue. The Board of Directors has approved a bonus ratio of 2:1, meaning shareholders will receive two fully paid-up equity shares of ₹10 each for every one existing equity share held. This issuance was previously approved by shareholders at the Annual General Meeting on June 30, 2026. The deemed date of allotment for these bonus shares will be the next working day following the record date (T+1). The new shares will rank pari passu with existing shares. Arrangements have also been made to adjust outstanding warrants to ensure holders receive equivalent economic benefits.